preview

Income Statement Of Pfizer Company

Satisfactory Essays

Income Statement of Pfizer Company for the fiscal year 31 March 2014 In Millions
Sales 100000
Cost of goods sold 45000
Gross Profits 55000
Operating Expenses
Selling, General and Administration Exp 10000
Research and development Expenses 15000
Total Operating Expenses 25000
Operating Income 30000
Interest Expenses 12000
Earnings before tax 18000
Income tax provision 5000
Net Income 13000

Statement of Cash Flow of Pfizer Company for the year ended on 31 March 2014 In Millions
Net Cash Flow from Operating Activities 35000
Net Cash Flow from Investing Activities (13500)
Net Cash Flow from Financing Activities (15500)
Net Increase in the cash and cash equivalent 6000
Cash and Cash equivalent beginning balance 35000
Cash and Cash equivalent Ending Balance 41000

Balance Sheet of Pfizer Company as on 31 March 2014 In Millions
Assets Amount in $ Liabilities and Equity Amount in $
Current Assets Current Liabilities
Cash and Cash Equiv. 41000 Account Payables 39500
Short term Investment 12000 Accrued & other Liab. 21500
Receivables 28000 Total current liability 61000
Inventories 40000 Long term debt 150000
Other Current Assets 27000 Other non-current liab 37000
Total Current Assets 148000 Total Liability 248000
Property Plant and Equipment 165000 Stock Holders Equity
Long term Investment 85000 Paid up Capital 170000
Other Noncurrent Assets 56000 Retained Earning 36000 Total stock holder equity

Get Access